WebNov 2, 2024 · Incyte Market Cap $16B Today's Change (-2.81%) -$2.03 Current Price $70.23 Price as of March 24, 2024, 10:00 a.m. ET INCY earnings call for the period ending … WebQ1 2024 Incyte Corporation Earnings Conference Call. May 2, 2024 at 8:00 AM EDT Add to Outlook. Add to Google Calendar. Click here for Webcast. Investor Contacts. Christine Chiou. Head of Investor Relations. 302.274.4773. [email protected]. Greg Shertzer, PharmD. Associate Director, Investor Relations ...
Exchange Traded Concepts LLC Has $2.03 Million Stock Holdings in Incyte …
WebFeb 8, 2024 · (RTTNews) - Incyte Corporation (INCY) will host a conference call at 8:00 AM ET on February 8, 2024, to discuss Q4 21 earnings results. To access the live webcast, log … WebApr 9, 2024 · Incyte Stock Performance. Shares of INCY opened at $75.51 on Friday. The company has a market capitalization of $16.84 billion, a price-to-earnings ratio of 49.68, a price-to-earnings-growth ratio of 3.20 and a beta of 0.73. Incyte Co. has a 52-week low of $65.07 and a 52-week high of $86.29. the ptb
Incyte Corporation
WebNov 1, 2024 · Q3 2024 Incyte Corporation Earnings Conference Call. Nov 1, 2024 at 8:00 AM EDT Click here for Webcast. Supporting Materials. Press Release. Q3 2024 Financial and Corporate Update Presentation 3.3 MB. Investor Contacts. Christine Chiou. Head of Investor Relations. 302.274.4773 ... WebAug 4, 2024 · NASDAQ: INCY Incyte Market Cap $18B Today's Change (-2.44%) -$1.98 Current Price $79.26 Price as of February 10, 2024, 4:00 p.m. ET INCY earnings call for the period ending June 30, 2024.... WebApr 15, 2024 · Incyte's quarterly revenue was up 7.4% on a year-over-year basis. On average, sell-side analysts forecast that Incyte Co. will post 3.29 earnings per share for the current year. Incyte Profile . Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. signia hearing aids tinnitus notch therapy